Cell and Gene Logistics

  1. Stability And Storage Testing 11/26/2024

    Receive comprehensive stability testing solutions that ensure the safety, efficacy, and quality of your pharmaceutical products at every stage of development by partnering with us.

  2. Solving The Leukopak Supply Chain Issue With Cryopreservation 11/25/2024

    Allogeneic cell therapy developers report an alarming number of starting materials arrive at the wrong temperatures, late, or fail to arrive altogether.

  3. Allogene's Mission To Democratize CAR-T 11/22/2024

    Allogene Therapeutics CEO and co-founder, David Chang, MD, Ph.D., talks about the exciting future of allogeneic CAR-T and shares the company's mission to bring these therapies to patients.

  4. Is The BIOSECURE Act The First Real Step Toward Reshoring? 11/22/2024

    The U.S. pharma industry has relied heavily on China and India to produce regulatory starting materials and APIs. The BIOSECURE Act has now emerged. Is this the first real step toward reshoring?

  5. Sourcing Plasmid DNA From CDMOs Got More Challenging — Here's Why 11/19/2024

    The demand for plasmid DNA products is intrinsically linked to unique market conditions and funding environments. Here's what's driving them.

  6. DEHP-Free Fluid Transfer Bags 11/13/2024

    Learn about fluid transfer bags that support biopharma manufacturing and are designed and packaged for bioprocessing applications as well as the storage and transportation of sterile fluids

  7. Breaking Through Supply Chain Bottlenecks In CGT 11/12/2024

    Industry experts share actionable solutions for tackling raw material variability, temperature-controlled logistics, and post-manufacturing storage, ensuring efficient, scalable operations.

  8. 3 Focus Areas To Transition From Clinical To Commercial Readiness 11/12/2024

    Transitioning from clinical-stage operations to commercial readiness is a multifaceted process. Establish compliant and robust distribution systems by focusing on these three areas.

  9. IntegriCell™ Cryopreservation Services From Cryoport Systems 11/7/2024

    IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.

  10. Strengthening The Pharmaceutical Supply Chain For Single-Use Assemblies 11/6/2024

    Dual sourcing strengthens the pharmaceutical supply chain for single-use assemblies. Learn how this strategy and multi-sourcing can enhance resilience and adaptability in the face of disruptions.